{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:23:15Z","timestamp":1791156195830,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T00:00:00Z","timestamp":1523232000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"DFG","award":["ER 155\/6-2"],"award-info":[{"award-number":["ER 155\/6-2"]}]},{"name":"DFG","award":["SI 236\/8-1"],"award-info":[{"award-number":["SI 236\/8-1"]}]},{"name":"DFG","award":["SI 236\/ 9-1"],"award-info":[{"award-number":["SI 236\/ 9-1"]}]},{"name":"IFORES"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00277-018-3305-x","type":"journal-article","created":{"date-parts":[[2018,4,8]],"date-time":"2018-04-08T23:26:18Z","timestamp":1523229978000},"page":"1463-1469","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Light chain monoclonal gammopathy of undetermined significance is characterized by a high disappearance rate and low risk of progression on longitudinal analysis"],"prefix":"10.1007","volume":"97","author":[{"name":"on behalf of the Heinz Nixdorf Recall Study Investigative Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt W.","family":"Pelzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Arendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Moebus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewin","family":"Eisele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"J\u00f6ckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"D\u00fchrsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7672-3905","authenticated-orcid":false,"given":"Jan","family":"D\u00fcrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,9]]},"reference":[{"issue":"9727","key":"3305_CR1","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","volume":"375","author":"A Dispenzieri","year":"2010","unstructured":"Dispenzieri A, Katzmann JA, Kyle RA, Larson DR, Melton LJ 3rd, Colby CL, Therneau TM, Clark R, Kumar SK, Bradwell A, Fonseca R, Jelinek DF, Rajkumar SV (2010) Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study. Lancet 375(9727):1721\u20131728. https:\/\/doi.org\/10.1016\/S0140-6736(10)60482-5","journal-title":"Lancet"},{"issue":"2","key":"3305_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00277-011-1293-1","volume":"91","author":"L Eisele","year":"2012","unstructured":"Eisele L, Durig J, Huttmann A, Duhrsen U, Assert R, Bokhof B, Erbel R, Mann K, Jockel KH, Moebus S, Heinz Nixdorf Recall Study Investigative G (2012) Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany. Ann Hematol 91(2):243\u2013248. https:\/\/doi.org\/10.1007\/s00277-011-1293-1","journal-title":"Ann Hematol"},{"issue":"8","key":"3305_CR3","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJMoa01133202","volume":"346","author":"RA Kyle","year":"2002","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ 3rd (2002) A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 346(8):564\u2013569. https:\/\/doi.org\/10.1056\/NEJMoa01133202","journal-title":"N Engl J Med"},{"issue":"2","key":"3305_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1067\/mhj.2002.123579","volume":"144","author":"A Schmermund","year":"2002","unstructured":"Schmermund A, Mohlenkamp S, Stang A, Gronemeyer D, Seibel R, Hirche H, Mann K, Siffert W, Lauterbach K, Siegrist J, Jockel KH, Erbel R (2002) Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. Am Heart J 144(2):212\u2013218","journal-title":"Am Heart J"},{"issue":"6","key":"3305_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10654-005-5529-z","volume":"20","author":"A Stang","year":"2005","unstructured":"Stang A, Moebus S, Dragano N, Beck EM, Mohlenkamp S, Schmermund A, Siegrist J, Erbel R, Jockel KH, Heinz Nixdorf Recall Study Investigation G (2005) Baseline recruitment and analyses of nonresponse of the Heinz Nixdorf Recall Study: identifiability of phone numbers as the major determinant of response. Eur J Epidemiol 20(6):489\u2013496","journal-title":"Eur J Epidemiol"},{"issue":"9","key":"3305_CR6","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","volume":"48","author":"JA Katzmann","year":"2002","unstructured":"Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, Kyle RA (2002) Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 48(9):1437\u20131444","journal-title":"Clin Chem"},{"issue":"9","key":"3305_CR7","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1373\/clinchem.2006.069104","volume":"52","author":"PG Hill","year":"2006","unstructured":"Hill PG, Forsyth JM, Rai B, Mayne S (2006) Serum free light chains: an alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies. Clin Chem 52(9):1743\u20131748. https:\/\/doi.org\/10.1373\/clinchem.2006.069104","journal-title":"Clin Chem"},{"issue":"11","key":"3305_CR8","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nrneph.2009.151","volume":"5","author":"CA Hutchison","year":"2009","unstructured":"Hutchison CA, Basnayake K, Cockwell P (2009) Serum free light chain assessment in monoclonal gammopathy and kidney disease. Nat Rev Nephrol 5(11):621\u2013628. https:\/\/doi.org\/10.1038\/nrneph.2009.151","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"3305_CR9","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","volume":"53","author":"AS Levey","year":"2007","unstructured":"Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F, Chronic Kidney Disease Epidemiology C (2007) Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 53(4):766\u2013772. https:\/\/doi.org\/10.1373\/clinchem.2006.077180","journal-title":"Clin Chem"},{"issue":"3","key":"3305_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00432-008-0470-7","volume":"135","author":"A Kuhnemund","year":"2009","unstructured":"Kuhnemund A, Liebisch P, Bauchmuller K, zur Hausen A, Veelken H, Wasch R, Engelhardt M (2009) \u2018Light-chain escape-multiple myeloma\u2019\u2014an escape phenomenon from plateau phase: report of the largest patient series using LC-monitoring. J Cancer Res Clin Oncol 135(3):477\u2013484. https:\/\/doi.org\/10.1007\/s00432-008-0470-7","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"3305_CR11","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1200\/JCO.2002.20.6.1625","volume":"20","author":"C Cesana","year":"2002","unstructured":"Cesana C, Klersy C, Barbarano L, Nosari AM, Crugnola M, Pungolino E, Gargantini L, Granata S, Valentini M, Morra E (2002) Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. J Clin Oncol 20(6):1625\u20131634. https:\/\/doi.org\/10.1200\/JCO.2002.20.6.1625","journal-title":"J Clin Oncol"},{"issue":"10","key":"3305_CR12","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1182\/blood-2003-03-0801","volume":"102","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR, Plevak MF, Melton LJ 3rd (2003) Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood 102(10):3759\u20133764. https:\/\/doi.org\/10.1182\/blood-2003-03-0801","journal-title":"Blood"},{"issue":"4","key":"3305_CR13","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1309\/AJCPT6OWWMHITA1Y","volume":"138","author":"DL Murray","year":"2012","unstructured":"Murray DL, Seningen JL, Dispenzieri A, Snyder MR, Kyle RA, Rajkumar SV, Katzmann JA (2012) Laboratory persistence and clinical progression of small monoclonal abnormalities. Am J Clin Pathol 138(4):609\u2013613. https:\/\/doi.org\/10.1309\/AJCPT6OWWMHITA1Y","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"3305_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1096-8652(200001)63:1<1::AID-AJH1>3.0.CO;2-M","volume":"63","author":"H Gregersen","year":"2000","unstructured":"Gregersen H, Mellemkjaer L, Salling Ibsen J, Sorensen HT, Olsen JH, Pedersen JO, Dahlerup JF (2000) Cancer risk in patients with monoclonal gammopathy of undetermined significance. Am J Hematol 63(1):1\u20136","journal-title":"Am J Hematol"},{"issue":"549","key":"3305_CR15","first-page":"221","volume":"82","author":"BM Colls","year":"1975","unstructured":"Colls BM, Lorier MA (1975) Immunocytoma, cancer and other associations of monoclonal gammopathy: a review of 224 cases. N Z Med J 82(549):221\u2013226","journal-title":"N Z Med J"},{"issue":"2","key":"3305_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0002-9343(77)90229-7","volume":"63","author":"A Solomon","year":"1977","unstructured":"Solomon A (1977) Homogeneous (monoclonal) immunoglobulins in cancer. Am J Med 63(2):169\u2013176","journal-title":"Am J Med"},{"issue":"10","key":"3305_CR17","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1182\/blood-2011-04-349134","volume":"118","author":"MJ Maurer","year":"2011","unstructured":"Maurer MJ, Cerhan JR, Katzmann JA, Link BK, Allmer C, Zent CS, Call TG, Rabe KG, Hanson CA, Kay NE, Slager SL, Witzig TE, Shanafelt TD (2011) Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia. Blood 118(10):2821\u20132826. https:\/\/doi.org\/10.1182\/blood-2011-04-349134","journal-title":"Blood"},{"issue":"12","key":"3305_CR18","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1200\/JCO.2010.29.4413","volume":"29","author":"MJ Maurer","year":"2011","unstructured":"Maurer MJ, Micallef IN, Cerhan JR, Katzmann JA, Link BK, Colgan JP, Habermann TM, Inwards DJ, Markovic SN, Ansell SM, Porrata LF, Johnston PB, Nowakowski GS, Thompson CA, Gupta M, Syrbu SI, Kurtin PJ, Macon WR, Nikcevich DA, Witzig TE (2011) Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma. J Clin Oncol 29(12):1620\u20131626. https:\/\/doi.org\/10.1200\/JCO.2010.29.4413","journal-title":"J Clin Oncol"},{"issue":"12","key":"3305_CR19","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1002\/ajh.23839","volume":"89","author":"TE Witzig","year":"2014","unstructured":"Witzig TE, Maurer MJ, Habermann TM, Link BK, Micallef IN, Nowakowski GS, Ansell SM, Colgan JP, Inwards DJ, Porrata LF, Markovic SN, Johnston PB, Lin Y, Thompson C, Gupta M, Katzmann JA, Cerhan JR (2014) Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma. Am J Hematol 89(12):1116\u20131120. https:\/\/doi.org\/10.1002\/ajh.23839","journal-title":"Am J Hematol"},{"issue":"4","key":"3305_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/ajh.23658","volume":"89","author":"TE Witzig","year":"2014","unstructured":"Witzig TE, Maurer MJ, Stenson MJ, Allmer C, Macon W, Link B, Katzmann JA, Gupta M (2014) Elevated serum monoclonal and polyclonal free light chains and interferon inducible protein-10 predicts inferior prognosis in untreated diffuse large B-cell lymphoma. Am J Hematol 89(4):417\u2013422. https:\/\/doi.org\/10.1002\/ajh.23658","journal-title":"Am J Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3305-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3305-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3305-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T09:04:46Z","timestamp":1604135086000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3305-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,9]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["3305"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3305-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,9]]},"assertion":[{"value":"11 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}